CHMP recommends approval of Eli Lilly's obesity drug
The European Medicines Agency’s (EMA) Scientific Committee for Medicinal Products for Human Use (CHMP) recommends that Eli Lilly’s Mounjaro be extended to treat obesity in patients with high BMI.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.